Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Ceapro Inc (CRPOF)

Ceapro Inc (CRPOF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 44,235
  • Shares Outstanding, K 77,673
  • Annual Sales, $ 11,290 K
  • Annual Income, $ 1,390 K
  • 60-Month Beta 2.16
  • Price/Sales 3.74
  • Price/Cash Flow 15.27
  • Price/Book 2.15
Trade CRPOF with:
  • Price/Earnings ttm 54.29
  • Earnings Per Share ttm 0.01
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 05/27/21
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.5400 +6.28%
on 06/24/21
0.5900 -2.73%
on 06/09/21
+0.0339 (+6.28%)
since 05/24/21
3-Month
0.4642 +23.63%
on 03/30/21
0.6376 -9.99%
on 04/13/21
+0.0339 (+6.28%)
since 03/24/21
52-Week
0.3600 +59.42%
on 07/13/20
0.7414 -22.59%
on 08/24/20
+0.1778 (+44.89%)
since 06/23/20

Most Recent Stories

More News
Ceapro Announces Results of 2021 Shareholders' Meeting

Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) ("Ceapro" or the "Company"), a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic...

CZO.VN : 0.700 (unch)
CRPOF : 0.5739 (+0.77%)
Ceapro Inc. Announces Completion of Patient Enrollment in Clinical Study Evaluating Beta Glucan as a Cholesterol-Lowering Agent

- Clinical study evaluating the well-known health claims of beta glucan and its potentially beneficial approach for patients to lower plasma cholesterol -

CRPOF : 0.5739 (+0.77%)
CZO.VN : 0.700 (unch)
Ceapro Inc. Reports 2021 First Quarter Financial Results and Highlights

- Maintained production operations during COVID-19 pandemic, providing customers essential products while ensuring the health and safety of Company's employees -

CRPOF : 0.5739 (+0.77%)
CZO.VN : 0.700 (unch)
Ceapro Inc. Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Highlights

Ceapro Inc. (TSX-V: CZO, OTCQX: CRPOF) ("Ceapro" or the "Company"), a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic...

CZO.VN : 0.700 (unch)
CRPOF : 0.5739 (+0.77%)
Ceapro Inc. Announces Successful Completion of Collaborative Research and Development Program with University of Alberta

- Project significantly advances broadening the application and utility of Ceapro's proprietary, first-in-class technologies to develop innovative delivery systems composed of new chemical complexes -

CZO.VN : 0.700 (unch)
CRPOF : 0.5739 (+0.77%)
Ceapro Inc. to Present at the H.C. Wainwright Global Life Sciences Conference

Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) ("Ceapro" or the "Company"), a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic...

CZO.VN : 0.700 (unch)
CRPOF : 0.5739 (+0.77%)
Ceapro Inc. to Present at NobleCon17

Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) ("Ceapro" or the "Company"), a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic...

CZO.VN : 0.700 (unch)
CRPOF : 0.5739 (+0.77%)
Ceapro Inc. to Present at the H.C. Wainwright BioConnect 2021 Virtual Conference

Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) ("Ceapro" or the "Company"), a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic...

CZO.VN : 0.700 (unch)
CRPOF : 0.5739 (+0.77%)
Ceapro Inc. Reports 2020 Third Quarter and Nine-Month Financial Results and Operational Highlights

- R&D activities focused on advancing the development of innovative delivery systems and yeast beta glucan as a potential inhalable therapeutic for COVID-19 -

CRPOF : 0.5739 (+0.77%)
Ceapro Inc. Announces Increased Financial Contribution from National Research Council of Canada for Innovative PGX Technology Project

Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) ("Ceapro" or the "Company"), a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic...

CRPOF : 0.5739 (+0.77%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

3rd Resistance Point 0.6191
2nd Resistance Point 0.5965
1st Resistance Point 0.5852
Last Price 0.5739
1st Support Level 0.5513
2nd Support Level 0.5287
3rd Support Level 0.5174

See More

52-Week High 0.7414
Fibonacci 61.8% 0.5957
Last Price 0.5739
Fibonacci 50% 0.5507
Fibonacci 38.2% 0.5057
52-Week Low 0.3600

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar